Rationale: Atrial fibrillation (AF) is the most common cardiac arrhythmia, however the mechanism(s) causing AF remain poorly understood and therapy is suboptimal. The ryanodine receptor (RyR2) is the major calcium (Ca 2+ ) release channel on the sarcoplasmic reticulum (SR) required for excitationcontraction coupling in cardiac muscle.
INTRODUCTION
Atrial fibrillation (AF) is the most common arrhythmia and is especially prevalent in the elderly 1 . AF accounts for more than one-third of all arrhythmia-related hospitalizations 2 . Although AF itself is not typically lethal, complications related to AF including thromboembolism, hemodynamic compromise and arrhythmogenesis make it one of the leading causes of cardiovascular morbidity and mortality. Current clinical management of AF is focused on rate control and chronic anticoagulation with concomitant potential bleeding risk and impaired cardiac function, especially in patients with congestive heart failure (CHF).
The mechanism of AF is not well understood despite more than 100 years of study. Most hypotheses regarding the induction of AF are based on observational studies in patients with chronic AF or studies of chronic AF animal models. Based on these studies, structural remodeling including atrial enlargement and fibrosis are proposed to play important roles in both triggering and maintaining AF 3 . However, it has proven difficult to distinguish whether these factors are the cause or the consequence of AF. Structural changes may directly or indirectly induce atrial electrical abnormalities leading to atrial ectopic events and AF. More recently, the role of Ca 2+ in AF has been explored as a possible contributing factor to the well-known reentry mechanism and in 'triggered activity' models 4 .
Our laboratory has reported that SR Ca 2+ leak via PKA hyperphosphroylated and/or oxidized RyR2 channels contributes to heart failure (HF) progression 5 and triggers ventricular arrhythmias [6] [7] [8] . Furthermore, we showed that CPVT-linked RyR2 mutations cause a diastolic SR Ca 2+ leak, delayed after depolarizations (DADs) and lethal ventricular arrhythmias in mice 6 . Recent reports demonstrate that patients with CPVT mutations have AF [9] [10] [11] [12] [13] . Mouse models harboring CPVT mutations recapitulate the ventricular human phenotype manifesting exercise-induced polymorphic VT and sudden death and studies with knock-in mice have helped to establish the role of diastolic SR Ca 2+ leak through mutant RyR2 in ventricular arrhythmias 6, [14] [15] [16] . The normal cardiac structure and function of CPVT mouse models makes them ideal tools to study the role of diastolic SR Ca 2+ leak via RyR2 in triggering AF in the absence of structural cardiac defects.
In the present study, AF was inducible by burst atrial pacing in mice harboring CPVT mutations in vivo but not in WT littermates. Moreover, we examined the difference in diastolic SR Ca 2+ leak between atrial and ventricular myocytes isolated from both WT and CPVT mice. Consistent with in vivo study results, there was an increase in diastolic SR Ca 2+ leak in atrial myocytes isolated from RyR2-R2474S +/-, RyR2-R2386I +/-, and RyR2-L433P +/-mice compared to atrial myocytes from WT mice. Increased diastolic SR Ca 2+ leak, associated with depletion of calstabin2 (FKBP12.6) from the RyR2 channel complex, was observed in atrial myocytes from RyR2-R2474S +/-mice, but not in WT mice. The small molecule Rycal S107, which stabilizes RyR2-calstabin2 interactions, significantly decreased the diastolic SR Ca 2+ leak in RyR2-R2474S +/-mice at the cellular level and prevented burst pacing-induced AF in vivo. These data suggest a role for diastolic SR Ca 2+ leak in initiating AF. Furthermore, inhibiting diastolic SR Ca 2+ leak with a Rycal could be a potential therapeutic approach for preventing AF.
METHODS
Detailed methods are provided in the Online Supplement including generation of RyR2-knock-in mice, murine atrial myocytes isolation, intracellular Ca 2+ measurements, measurement of total SR Ca 2+ leak, intra-esophageal burst pacing, intra-cardiac burst pacing ECG recording, immunoprecipitation and immunoblot analyses. S107 and Metoprolol treatment. S107 and metoprolol were diluted in drinking water at concentrations of 0.25 mg/ml and 0.1 mg/ml respectively. The drinking water was changed every week and the water consumption was recorded. There were no differences in water consumption between vehicle, S107 or metoprolol treated groups.
Statistical analysis.
Data are reported as mean ± s.e.m unless otherwise indicated. In vivo AF stimulation studies were analyzed with chi-square. P < 0.05 was accepted as statistically significant. All experiments with animals were approved by Columbia University's Institutional Animal Care and Use Committee.
RESULTS

Atrial fibrillation (AF) in CPVT mouse models.
Diastolic SR Ca
2+ leak via mutant RyR2 triggers lethal ventricular arrhythmias during stress in CPVT patients [6] [7] [8] 14 . However, whether these mutant RyR2 in atria lead to atrial arrhythmias is not clear, although there are several clinical case reports demonstrating atrial premature complexes which may trigger atrial tachycardia, atrial flutter or AF in CPVT patients [9] [10] [11] [12] [13] 17 . As we have shown previously, RyR2-R2474S +/-mice developed typical bidirectional ventricular tachycardia (VT) and polymorphic VT during stress, which mimics the human CPVT phenotype 6 . To further study the molecular mechanism of CPVT, we generated two new mice harboring human CPVT mutations: RyR2-N2386I +/-and RyR2-L433P +/-. Using stress protocols we confirmed the phenotype of these two new CPVT mouse models (supplemental figure I ).
An intra-esophageal pacing method was developed to verify the role of diastolic SR Ca 2+ leak via RyR2 in AF using three CPVT knock-in mouse models. In these experiments, the left atrium was paced via an intra-esophageal pacing catheter using a previously reported atrial burst pacing protocol 18 . Compared to WT mice which exhibited no AF under these conditions, mice harboring CPVT mutations could be stimulated into AF by atrial burst pacing (RyR2-R2474S +/-; 7/10, RyR2-N2386I +/-; 9/15, RyR2-L433P +/-; 5/14 ( Figures 1 A and B) . The duration of AF and heart rate during atrial burst pacing-induced AF were similar among the groups (data not shown). To further verify the AF induced by intraesophageal burst pacing, an octapolar catheter was introduced into the right ventricle via the jugular vein to record intra-cardiac ECGs during intra-esophageal pacing in three RyR2-N2386I +/-mice. AF events recognized on surface ECGs in these mice were confirmed by the presence of typical irregular atrial waves recorded from the intra-cardiac atrial leads ( Figure 1C ).
Sarcoplasmic reticulum Ca
2+ leak in atrial myocytes from CPVT mice.
To further explore the mechanism of increased prevalence of atrial burst pacing-induced AF in CPVT mice, we characterized the SR Ca 2+ release in atrial myocytes isolated from CPVT and WT mice. Ca 2+ spark frequencies were significantly increased in atrial myocytes from RyR2-R2474S +/-(5.59±0.49
/100 m/s), RyR2-N2386I +/-(4.63±0.63 /100 m/s) and RyR2-L433P +/-(4.14±0.45 /100 m/s) compared to WT myocytes (2.60±0.39 /100 m/s, P<0.05, Figure 2B ). As the morphologies of Ca 2+ sparks showed profound variations between these groups (Figure 2A ), we developed a new parameter (methods described in supplemental data) to quantitatively assess the total SR Ca 2+ leak between different groups. The results of total SR Ca 2+ leak were similar to but more profound than that measured by Ca 2+ spark frequencies. In agreement with the results of diastolic SR Ca 2+ leak, the SR Ca 2+ content in atrial myocytes isolated from RyR2-R2474S +/-, RyR2-N2386I +/-, and RyR2-L433P +/-mice were decreased compared to WT atrial myocytes F/F 0 : 6.93±0.38, 7.16±0.30, and 7.28±0.32 vs 8.47±0.42 in WT, P<0.05, Figure 2C ). Figure 2C ).
S107 prevents SR
Decreased calstabin2 binding to RyR2 in atria but not ventricles isolated from RyR2-R2474S +/-mice.
As we previously reported, PKA phosphorylation of RyR2 and castabin2 binding to RyR2 were unchanged in ventriclular cardiomyocytes from RyR2-R2474S +/-mice compared to WT littermates 6 . Stress-induced PKA phosphorylation of the channel depletes calstabin2 from RyR2 causing diastolic SR Ca 2+ leak and ventricular arrhythmias 6 . In the present study atrial burst pacing did not cause PKA phosphorylation of RyR2 ( Figure 3A and 3B); instead, it caused CaMKII phosphorylation of RyR2 as previously reported 22, 23 (supplemental figure XII) . However, compared to WT mice, the calstabin2 level was significantly decreased in atrial RyR2 immunoprecipitated from RyR2-R2474S +/-mice. This was not the case in ventricular immunoprecipitates as we previously reported 6 .
To further explore the cause of this difference between atrial and ventricular RyR2, we examined the PKA phosphorylation, oxidation and nitrosylation of RyR2 in atrial and ventricular tissues from WT and RyR2-R2474S +/-mice. We previous reported that RyR2 are oxidized and nitrosylated in cardiomyocytes from a knock-in mouse harboring RyR2 that mimic constitutively PKA hyperphosphorylated channels, RyR2-S2808D, as well as in human, rat and mouse HF 21 . Interestingly, the RyR2 from atrial tissue in RyR2-R2474S +/-mice exhibited increased oxidation but no detectable PKA phosphorylation or nitrosylation. In contrast there was no oxidation, PKA phosphorylation, or nitrosylation of atrial RyR2 from WT mice ( Figure 3A and 3B). The cause of atrial RyR2-R2474S +/-channel oxidation is unknown, but provides an explanation for the depletion of calstabin2 from the RyR2 channel complex in atrial tissue of RyR2-R2474S +/-mice.
In order to explore the mechanism underlying S107 treatment in prevention of both burst pacinginduced AF and diastolic R Ca 2+ leak in RyR2-R2474S +/-mice, we examined castabin2 binding and oxidation of atrial RyR2 in atrial samples from WT and RyR2-R2474S +/-mice. S107 inhibited depletion of calstabin2 from the RyR2 channel complex without reducing RyR2 oxidation ( Figure 3C ). Since oxidation of the RyR2 channel complex was observed in RyR2-R2474S +/-atria, to test whether RyR2 oxidation can cause calstabin2 depletion from the channel complex, we applied the antioxidant DTT to atria from RyR2-R2474S +/-mice. Incubation with DTT reversed the oxidation of RyR2 and restored calstabin2 binding to RyR2 to levels comparable to those observed in RyR2 from WT atria ( Figure 3D ).
Atrial burst pacing-induced AF in PLN-KO and PLN-DM mice.
Atrial burst pacing did not induce AF in phospholamban (PLN)-DM mice in which SR Ca 2+ content is not increased by adrenergic stimulation due to mutations in the PKA and CaMKII phosphorylation sites in PLN 24 (Table 1) . However, in PLN knockout mice, in which SR Ca 2+ is maximally loaded, the prevalence of atrial burst pacing-induced AF was 37.5% (3/8) ( Table 1) . Thus, atrial burst pacing-induced AF in mice can be triggered by leaky RyR2 and/or SR Ca 2+ overload and preventing adrenergic or rate related increases in SR Ca 2+ content can inhibit AF triggered by leaky RyR2 channels.
S107 prevents atrial burst pacing-induced AF in RyR2-R2474S
+/-and RyR2-N2386I +/-mice.
RyR2-R2474S
+/-and RyR2-N2386I +/-mice were treated with S107 in the drinking water (20 mg/kg/day) for two weeks. Compared to control groups, S107 treatment significantly decreased the susceptibility to AF in both RyR2-R2474S +/-(from 70% to 0%, Figure 4A ) and RyR2-N2386I +/-(from 60% to 9.1%, Figure 4B ) mice, indicating that diastolic SR Ca 2+ leak plays a major role in atrial burst pacing-induced AF in these CPVT mice.
Increased SR Ca 2+ leak in atrial vs. ventricular myocytes from RyR2-R2474S +/-mice.
The difference in calstabin2 binding to RyR2 and increased oxidation in atrial RyR2 but not in ventricular RyR2 in RyR2-R2474S +/-mice could result in differences in diastolic SR Ca 2+ leak between atria or ventricular cardiomyocytes. We isolated atrial and ventricular cardiomyocytes from WT and RyR2-R2474S +/-mice and compared diastolic SR Ca 2+ leaks. As reported previously 25 , ventricular myocytes isolated from RyR2-R2474S +/-mice exhibited higher Ca 2+ spark frequencies compared to ventricular myocytes isolated from WT mice. Interestingly, the Ca 2+ spark frequencies of atrial myocytes were higher than their ventricular counterparts in both WT and RyR2-R2474S +/-mice ( Figure 5A ), indicating an intrinsic difference in Ca 2+ cycling between atria and ventricles. These findings are consistent with in vivo programmed electrical stimulation results in which the same burst pacing protocol introduced via both atrial (intra-esophageal) and ventricular (endocardial) routes in RyR2-R2474S +/-mice resulted in only atrial but not ventricular burst pacing-induced arrthythmias ( Figure 5B ). In addition, the Ca 2+ spark frequencies in atrial myocytes isolated from WT mice and ventricular myocytes from RyR2-R2474S +/-mice were similar indicating a higher resting diastolic SR Ca 2+ leak rate in atrial myocytes vs. ventricular myocytes. These data are consistent with in vivo data showing that without stress (exercise + epinephrine), none of RyR2-R2474S +/-or WT mice can be stimulated into ventricular arrhythmias and AF, respectively.
Calstabin2 knockout mice have increased atrial burst pacing-induced AF which was not prevented by S107 treatment.
Although our previous work showed that both the 1,4-benzothiazepine JTV519 and the Rycal S107 prevent diastolic SR Ca 2+ leak in murine models of heart failure and ventricular arrhythmias by preventing the stress induced depletion of calstabin2 from the RyR2 macromolecular complex 5, 6, 8, 19, [26] [27] [28] [29] , the mechanism of these drugs continues to be questioned 8 . In order to clarify the molecular mechanism of S107 we tested the effect of S107 in calstabin2 knockout mice. Consistent with a previous report 20 , compared to WT, calstabin2 knockout mice showed significantly increased prevalence of AF with intraesophageal burst pacing ( Figure 6A and 6B). After 2-weeks of oral S107 (20 mg/kg/day delivered in the drinking water), the incidence of AF by atrial burst pacing was not changed in calstabin2 knockout mice, indicating that the mechanism of action of S107 depends on the presence of calstabin2. Consistent with these in vivo experiments, atrial myocytes isolated from calstabin2 knockout mice showed significantly increased Ca 2+ spark frequencies that were not reduced by incubation with S107 ( Figure 6C ).
The role of CaMKII phosphorylation of RyR2 in atrial burst pacing-induced AF in mice with CHF.
It has been reported that CaMKII phosphorylation of RyR2 is a major cause of SR Ca 2+ leak in atrial myocytes with RyR2 mutations and leads to AF 22, 23, 30 . To test the role of CaMKII phosphorylation of RyR2 in triggering AF, we examined AF in a knock-in mouse, RyR2-S2814A, harboring an RyR2 that cannot be CaMKII phosphorylated. In agreement with a previous report by Chelu et al. 22 there was no AF stimulated in RyR2-S2814A mice by our intra-esophageal burst pacing protocol. To further confirm the activation of CaMKII during our intra-esophageal burst pacing procedure, we showed that RyR2 CaMKII phosphorylation at Ser2814 in our WT and CPVT mice was increased 22, 23, 31 (supplemental figure XII) . However, as we previously reported, RyR2-S2814A knock-in mice were not protected against heart failure after myocardial infarction 32 . Moreover, there was no difference in pacing-induced AF between WT and RyR2-S2814A mice (50.0% vs. 63.6%), indicating that in mice with post-MI heart failure, the CaMKII phosphorylation of RyR2 does not play a pivotal role in atrial burst pacing-induced AF (supplemental figure V).
Catecholamines do not play an important role in atrial burst pacing-induced AF in 3 CPVT mouse models.
CPVT is characterized by stress-induced polymorphic ventricular arrhythmias. To further explore the role of sympathetic activation in atrial burst pacing-induced AF in CPVT mouse models, we treated CPVT mice with metoprolol, a β-blocker, via drinking water for 4 weeks in a previously reported dose (30 mg/kg/day) 21 . Compared to vehicle groups, there was no significant therapeutic effect of metoprolol in the CPVT mice (supplemental figure VI), suggesting that activation of sympathetic system likely does not play an important role in triggering AF in our CPVT mouse models.
DISCUSSION
SR Ca
2+ leak triggers AF.
Although SR Ca 2+ leak has been observed in cardiomyocytes from chronic AF patients 33 , it is still not clear whether SR Ca 2+ leak is the cause of or results from AF. Chronic sustained AF leads to atrial remodeling of both heart structure (increased fibrosis and atrial dilatation) and ion channel function 34 . We previously showed that there is RyR2 PKA hyperphosphorylation and calstabin2 dissociation from RyR2 in atrial samples from humans with AF and in an animal model with chronic AF 35 . These findings suggested that dynamic molecular changes to RyR2 channels occur during chronic AF and that these changes may relate to the maintenance of AF. In the current study, using knock-in mouse models harboring human CPVT mutations which have diastolic SR Ca 2+ leak without structural or functional abnormalities in the heart (supplemental figure IV) , we explored the molecular basis of pacing-induced AF in detail. The CPVT mice had a significantly higher prevalence of pacing-induced AF compared to WT littermates. In isolated atrial myocytes from these mice, diastolic SR Ca 2+ leak was significantly increased compared to WT atrial myocytes. This increased diastolic SR Ca 2+ leak in myocytes isolated from all three CPVT mouse models was associated with decreased SR Ca 2+ content compared to WT, indicating that a sustained diastolic SR Ca 2+ leak via RyR2 occurs in atrial myocytes.
Calstabin2 dissociation leads to SR Ca 2+ leak and burst pacing-induced AF.
Both congestive heart failure (CHF) and CPVT are characterized by calstabin2 dissociation from the RyR2 macromolecular complex resulting in "leaky" RyR2 channels. Our previous work showed that RyR2-castabin2 binding stabilizes the RyR2 channel complex and prevents diastolic SR Ca 2+ leak in CHF or CPVT 6, 19, 21, 36, 37 . The role of castabin2 binding to RyR2 in AF was first reported in myocytes from human chronic AF patients 35 and Sood et al. showed endocardial right atrial burst pacing could induce AF in calstabin2 knockout mice 20 . Our intra-esophageal pacing protocol showed a significant increase in AF prevalence in calstabin2 knockout mice and S107 treatment failed to inhibit the burst pacing-induced AF in vivo and diastolic SR Ca 2+ leak in vitro in calstabin2 deficient mice. However, in the CPVT models, in contrast to ventricular arrhythmias that are induced by both exercise and epinephrine, AF was induced by fast atrial pacing without any catecholamine treatment. Inhibition of sympathetic activity by the β-blocker metoprolol did not suppress AF in our CPVT mouse models (supplemental figure VI) , further indicating that catecholamines may not be important in triggering AF in CPVT. This discrepancy between atrial and ventricular arrhythmias in the CPVT mouse models is likely explained by the depletion of calstabin2 from the RyR2 molecular complex in atrial but not ventricular tissues from resting RyR-R2474S +/-mice ( Figure 3 ). We previously reported that the dissociation of calstabin2 from RyR2 is caused by remodeling of the RyR2 channel complex including PKA phosphorylation, nitrosylation, and oxidation of RyR2 21 . We now show that RyR2 from RyR2-R2474S +/-atrial tissue are oxidized at baseline indicating chronic remodeling of the channel in this CPVT mouse. Indeed, clinical reports have suggested a close link between elevated levels of derivatives of reactive oxygen metabolites and persistent AF and AF recurrence after radio frequency catheter ablation in paroxysmal AF patients 38 . We previously showed that oxidation and PKA phosphorylation cause calstabin2 depletion from RyR2 21 . We now show that calstabin2 dissociation from RyR2 can occur when the channel is oxidized. Using the reducing reagent DTT to inhibit RyR2 oxidation in atrial tissue isolated from RyR2-R2474S +/-mice we further examined the role of RyR2 oxidation in depletion of calstabin2 from the RyR2 channel complex in our CPVT mouse model. It is possible that the CPVT mutations may alter RyR2 conformation rendering it more accessible to oxidation and more sensitive to calstabin2 depletion.
Restoring calstabin2 binding to RyR2 stabilizes the channel and prevents burst pacing-induced AF.
As we previously reported 6, 21, 26, 27 , S107 stabilizes RyR channels and prevents Ca 2+ leak by enhancing RyR-calstabin interactions. Here we show that incubation of atrial myocytes isolated from RyR2-R2474S +/-mice with S107 inhibited diastolic SR Ca 2+ leak. S107 treatment of mice also prevented intra-esophageal burst pacing-induced AF in RyR2-R2474S +/-, RyR2-N2386I +/-mice but had no effect in mice lacking calstabin2. The effect of S107 in stabilizing leaky RyR2 channels in the atria indicates that dissociation of calstabin2 from RyR2 channel complex likely plays an important role in AF in these CPVT mouse models. Furthermore, according to the Framingham Study, CHF is the strongest predictor for the development of AF 39 . CHF results in RyR2 PKA hyperphosphorylation, oxidation, nitrosylation and calstabin2 dissociation from RyR2 molecular complex. Dissociation of calstabin2 from the RyR2 channel complex could be one of the causes of AF in patients with CHF. Therefore, the RyR2 stabilizing Rycal S107 has potential as a possible therapeutic for the prevention and treatment of AF related to CHF or CPVT. 22, 23, 31 , our experiment using freshly isolated atria from WT and RyR2-R2474S +/-mice with or without atrial burst pacing showed that atrial burst pacing led to RyR2 CaMKII phosphorylation at Ser2814 in both groups (supplemental figure XII), suggesting a role for CaMKII phosphorylation of RyR2 during atrial burst pacing induced AF. To further clarify the role of CaMKII phosphorylation of RyR2 in triggering AF, we used a clinically relevant acute myocardial infarction induced HF model as AF occurs in 15% to 30% of patients with HF 40 . According to our previously published results, RyR2-S2814A mice showed similar progression of heart failure after myocardial infarction compared to WT littermates 32 . In these HF mice, the atrial burst pacing protocol induced similar incidences of AF in both RyR2-S2814A and WT groups, arguing that CaMKII phosphorylation of RyR2 does not play a major role in triggering AF in HF. However, due to the multiple substrates of CaMKII in Ca 2+ cycling proteins, the role of pacing-induced activation of CaMKII in modulating Ca 2+ cycling requires further study.
The different characteristics of arrhythmias between atria and ventricles.
Increased diastolic SR Ca 2+ leak in atrial myocytes isolated from RyR2-R2474S +/-mice is consistent with in vivo intra-esophageal and intra-cardiac burst pacing-induced AF and ventricular arrhythmias respectively in RyR2-R2474S +/-mice ( Figure 6 ). A recent report showed that rat atrial myocytes have higher SR mediated Ca 2+ uptake and a ~3-fold higher SR Ca 2+ load compared to ventricular myocytes 41 . Higher SR Ca 2+ load and increased SR Ca 2+ uptake may explain the increased Ca 2+ spark frequencies in both WT and RyR2-R2474S +/-atrial myocytes compared to their ventricular counterparts and may lower the threshold for induction of atrial arrhythmias induced by burst atrial pacing. The baseline Ca 2+ spark frequencies of WT atrial myocytes and RyR2-R2474S +/-ventricular myocytes were comparable ( Figure 5 , first and fourth bar), indicating comparable diastolic SR Ca 2+ leak. This leak by itself is not sufficient to induce AF during in vivo burst pacing stimulation in WT mice, or ventricular arrhythmias in RyR2-R2474S +/-mice. Clinically, VT is observed during exercise in patients with the RyR2-R2474S mutation indicating the importance of sympathetic activation of the SR Ca 2+ uptake pathway and loading of the SR to increase the amplitude of the leak. The exact reasons for these differences are still not well understood. However, it is well known that unlike ventricular fibrillation which leads to sudden cardiac death, AF is typically not lethal in the absence of a by-pass tract. Therefore there might be less evolutionary pressure to maintain a higher threshold for arrhythmias in the atria.
Mechanism of AF.
Although re-entry and multiple wavelets are observed in AF, the molecular events initiating AF remain uncertain. In the current study using CPVT mouse models with known RyR2 mutations and normal cardiac structure and function (supplemental figure IV) , we explored the role of diastolic SR Ca 2+ leak via mutant RyR2 in the atria. In agreement with previous reports implicating abnormal Ca 2+ handling in AF, we did observe Ca 2+ waves (supplemental figure IX) and indirect evidence of Ca 2+ -activated inward current (DAD, supplemental figure VIII) in our studies. Together with the normal cardiac structure and function of the CPVT mouse models, our data indicate that the diastolic SR Ca 2+ leak via RyR2 leads to Ca 2+ waves and DADs which form multiple wavelets and possible re-entry loops that trigger atrial tachycardia (AT) and AF.
Limitations and disadvantages.
The CPVT RyR2 mutations in our study were originally discovered in CPVT patients. However, due to the low prevalence of CPVT in population and extremely low number of patients with each specific RyR2 mutation there are no reports of AF in patients with RyR2-R2474S, RyR2-N2386I, or RyR2-L433P mutations. Due to technical limitations, it is impossible to pace a single cardiomyocyte at physiologic frequencies (for mice) e.g. 9-10Hz. Therefore, the Ca 2+ spark measurements may not reflect physiological conditions in intact atria. Also, the burst pacing protocol needed to elicit AF in mice may not represent maintained AF in humans. In addition, abnormal function of pacemaker cells in the CPVT mouse models is potentially a factor in triggering AF.
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Brittsan Figure 1 . Intra-esophageal burst pacing induces AF in three murine CPVT models. A) Representative surface ECG traces from WT, RyR2-R2474S +/-, RyR2-N2386I +/-, and RyR2-L433P +/-mice during intra-esophageal burst pacing. B) Prevalence of AF in WT (n=33), RyR2-R2474S +/-(n=10), RyR2-N2386I +/-(n=15), and RyR2-L433P +/-(n=14) mice during intra-esophageal burst pacing. *, P<0.05 vs. WT. C) Representative AF in surface and intra-cardiac ECG trace from a RyR2-N2386I +/-mouse after intraesophageal burst pacing stimulation (I, II, and aVR, surface leads; V, ventricular leads; A/V, atrioventricular node leads; A, atrial leads). +/-mice. AF was stimulated by a intra-esophageal pacing protocol, ventricular arrhythmias were stiumlated by an intra-cardiac pacing protocol (n=10 in both groups). *, P<0.05 vs. ventricular arrhythmias. Figure 6 . S107 has no effect on atrial burst pacing-induced AF in castabin2 KO mice. A) Representative surface ECG traces from a calstabin2 KO mouse treated with vehicle or S107. B) Prevalence of AF in calstabin2 KO mice in vehicle (n=10) and S107 treatment (n=12) groups during intra-esophageal burst pacing. C) Atrial myocytes isolated from calstabin2 KO mice were incubated with 10 µM S107 for 2 hrs before sampling for Ca 2+ spark frequencies (n=13 cells in both groups).  Recent reports show that CPVT patients have increased prevalence of AF.
What New Information Does This Article Contribute?
 Diastolic SR Ca 2+ leak likely plays a critical role in initiating AF in murine models of human CPVT-linked RyR2 mutations.
 S107 (Rycal) significantly inhibits diastolic SR Ca 2+ leak in atrial myocytes and prevents pacinginduced AF in models of human CPVT-linked RyR2 mutations.
Atrial fibrillation (AF) is the most common cardiac arrhythmia. However, the mechanisms underlying AF are not well understood despite more than 100 years of study. This has impaired the development of therapeutics for AF. Intracellular Ca 2+ plays a central role in the action potential and contraction of atrial myocytes. While the role of diastolic SR Ca 2+ leak in the generation of ventricular arrhythmias has been demonstrated, the impact of diastolic SR Ca 2+ leak in the genesis of AF remains to be established. It has been shown that CPVT-linked RyR2 mutations cause diastolic SR Ca 2+ leak, delayed after depolarizations and lethal ventricular arrhythmias. Recent reports demonstrate that patients with CPVT-linked RyR2 mutations have a higher prevalence of AF as well. Murine models harboring CPVT-linked RyR2 mutatoins exhibit increased burst pacing-induced AF. Atrial myocytes isolated from these mice showed increased diastolic SR Ca 2+ leak. The rycal drug S107 that inhibits loss of the stabilizing subunit calstabin2 from the RyR2 macromolecular complex inhibited diastolic SR Ca 2+ SR leak and prevented burst pacing-induced AF in murine models of CPVT-linked RyR2 mutations. These findings indicate that inhibition of diastolic SR Ca 2+ leak with a rycal drug could be a potential therapeutic approach for preventing AF. Figure IB) . Thus, the 3 CPVT mouse models recapitulated the CPVT phenotype.
Generation of RyR2-N2386I knock-in mouse
The targeting vector for homologous recombination consisted of an 8.9-kb genomic DNA fragment including exons 44-51 of the RyR2 genomic sequence. The 5' and 3' flanking regions were amplified from 129S mouse genomic DNA using PCR with the following 2 sets of primers: Figure IIC) .
Generation of RyR2-L433P knock-in mouse
A targeting construct for homologous recombination was constructed using the BAC modification system 4, 5 . A 200 kb fragment of C57BL/6 BAC clone containing RyR2 genomic sequence was purchased from Cori.org. It was designed to introduce a leucine to proline mutation in E15 by galk selection 6 , along with a loxp-neo-loxp cassette and DTA cassette insertion in upstream of E15 by Red system (Supplemental Figure IIIA) . This targeting construct containing BAC was linearized and electroporated into C57BL/6 129 sv hybrid embryonic stem cells. Targeted clones were identified by PCR using primer: 5'-TGGTTTCCTTTGCCTGGTTT located in the region where the RyR2 sequences were replaced by DTA cassette, and 3' primer:
5'-CCTACCGGTGGATGTGGAAT located in the neo cassette (Supplemental Figure IIIB) . Two of these targeted clones were injected into blastocytes. Heterozygous mice carrying the targeted allele were obtained. They were mated with Ell2a Cre transgenic mice to remove the neo cassette flanked by a pair of loxp sites. Mice carrying the L433P knock-in allele were identified by a PCR genotyping using the following primer: 5'-AGCAAATGTCAGTGCTTGAAGA and 3'-CCTGAATCACAGCAAACACTTC (Supplemental Figure IIIC) .
Generation of RyR2-R2474S knock-in mouse was as previously described 1 .
Murine atrial myocytes isolation
Atrial myocytes were isolated from WT and CPVT mice according to a modified version of AfCS Procedure Protocol PP00000125. Briefly, the heart was perfused with AfCS perfusion buffer, includes (mM): NaCl 113, KCl 4.7, KH 2 PO 4 0.6, Na 2 HPO 4 0.6, MgSO 4 1.2, NaHCO 3 12, KHCO 3 10, Hepes 10, taurine 30, glucose 1.5 and BDM 10, for 5 min at a speed of 3ml/min after rapidly excised and canulated. The isolated heart was then perfused with digestion buffer (0.65 mg/mL Collagenase type 2 and 50 µM CaCl 2 in AfCS) for 10~15 min. After enzyme digestion of the heart was complete (heart appeared swollen, pale and flaccid), the atria were excised and teased into small pieces in stop 1 buffer (0.65 mg/mL Collagenase type 2, 0.065 mg/mL Protease XIV, 15 mg/mL BSA and 50 µM CaCl 2 in AfCS) and bath at 37°C for 10 min. Pipets were used to dissociate the heart tissue gently until all large pieces were dispersed. After The scan zoom was adjusted to fit the cells, and the scan line was along the long axis of cells.
Intracellular calcium measurements
The excitation for Fluo-4 is 488 nm, and emission was collected at 505-530 nm. For Ca 2+ sparks measurement, cells were scanned at 400 Hz for 20 s immediately after pacing at 0.5 Hz > 20
beats. For SR Ca 2+ content measurement, cells were exposed to 10 mM caffeine immediately after pacing at 0.5 Hz for 1 min, and sampling started 10 s before caffeine treatment. For S107 treatment, cells were pre-treated with 10 µM S107 for 2 hrs before loading and imaging. Ca 2+ sparks detection and analyses used algorithms described previously 7 .
Total SR Ca 2+ leak
The background noise of a confocal laser scan images follows a Poisson distribution.
For a normalized linescan image, the background noise can be fit into a modified Gaussian (   (S2) where, x is normalized fluorescence and ΔN is the difference between real and fitted curves.
Intra-esophageal burst pacing in mouse
Intra-esophageal pacing was performed using either a 1.1-Fr octapolar catheter (EPR-800, Millar Instruments, Houston, Texas) or 1-Fr bipolar pacing catheter (model EP118-2, NuMED; Hopkinton, NY) placed in the esophagus close to the left atrium using an external stimulator (STG-3008, MultiChannel Systems, Reutlingen, Germany). A computerized data acquisition system (EMKA Technologies, Falls Church, VA) was used to record a 3-lead body surface ECG, and up to 4 intra-esophageal bipolar electrograms. Inducibility of atrial arrhythmias was tested by applying a series of 2-second bursts. The first 2-second burst had a cycle length (CL) of 40 ms, and CL was decreased in each successive 2-ms decriments until reaching a CL of 10 ms. These series of bursts were repeated once. AF was defined as a period of rapid irregular atrial rhythm lasting at least 1 sec. If 1 or more bursts in the 2 series of bursts evoked an AF episode, AF was considered to be inducible in that animal; otherwise, AF was considered to be non-inducible. All data were analyzed by two independent board certified electrophysiologists blinded to the genotype and treatment groups of the animals.
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